H1, a healthcare data platform, has secured $40 million in a Series C funding round led by STAT-ter Capital, with participation from existing investors like Andreessen Horowitz and Menlo Ventures. This follows a $100 million Series B in 2022, marking a significant follow-on investment. The company plans to leverage these funds to further develop its AI-powered clinical data solutions and expand its global reach.
H1 Growth — H1